Sequoia: Results of a randomized phase iii trial of zanubrutinib versus bendamustine plus rituximab (br) in patients with previously untreated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)

Greil, R (author)

Robak, T (author)

Giannopoulos, K (author)

show more...

Jurczak, W (author)

Simkovic, M (author)

Shadman, M (author)

Osterborg, A (author)

Laurenti, L (author)

Walker, P (author)

Opat, S (author)

Chan, H (author)

Ciepluch, H (author)

Tani, M (author)

Trneny, M (author)

Brander, DM (author)

Flinn, IW (author)

Grosicki, S (author)

Verner, E (author)

Brown, JR (author)

Kahl, BS (author)

Ghia, P (author)

Li, J (author)

Tian, T (author)

Zhou, L (author)

Marimpietri, C (author)

Paik, JC (author)

Cohen, A (author)

Hillmen, P (author)

Tam, CS (author)

show less...

2022

2022

English.

In: ONCOLOGY RESEARCH AND TREATMENT. - 2296-5270. ; 45:SUPPL 2, s. 117-118

Related links:

http://kipublication...

• Conference paper (other academic/artistic)